Literature DB >> 14570400

A metabolic basis for Alzheimer disease.

George Perry1, Akihiko Nunomura, Arun K Raina, Gjumrakch Aliev, Sandra L Siedlak, Peggy L R Harris, Gemma Casadesus, Robert B Petersen, William Bligh-Glover, Elizabeth Balraj, Grace J Petot, Mark A Smith.   

Abstract

Most studies of Alzheimer's disease (AD) have focused on a single precipitating alteration as the etiological event rather than global changes closely linked to aging. Recent evidence suggests that the most significant of these global changes are metabolic. Here we present data indicating that metabolic rate, nutrition, and neuronal size are all early indicators of AD. Understanding the cellular and molecular basis for these changes may open a new dimension to understanding AD.

Entities:  

Mesh:

Year:  2003        PMID: 14570400     DOI: 10.1023/a:1025678510480

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  21 in total

1.  Amyloid beta-peptide inhibits neuronal glucose uptake by preventing exocytosis.

Authors:  E Uemura; H W Greenlee
Journal:  Exp Neurol       Date:  2001-08       Impact factor: 5.330

2.  Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation.

Authors:  Adam D Cash; Gjumrakch Aliev; Sandra L Siedlak; Akihiko Nunomura; Hisashi Fujioka; Xiongwei Zhu; Arun K Raina; Harry V Vinters; Massimo Tabaton; Anne B Johnson; Manuel Paula-Barbosa; Jesus Avíla; Paul K Jones; Rudy J Castellani; Mark A Smith; George Perry
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

3.  Diet and oxidative stress: a novel synthesis of epidemiological data on Alzheimer's disease.

Authors:  M A Smith; G J Petot; G Perry
Journal:  J Alzheimers Dis       Date:  1999-11       Impact factor: 4.472

Review 4.  Alzheimer's disease: the amyloid cascade hypothesis.

Authors:  J A Hardy; G A Higgins
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

5.  Oxidative damage is the earliest event in Alzheimer disease.

Authors:  A Nunomura; G Perry; G Aliev; K Hirai; A Takeda; E K Balraj; P K Jones; H Ghanbari; T Wataya; S Shimohama; S Chiba; C S Atwood; R B Petersen; M A Smith
Journal:  J Neuropathol Exp Neurol       Date:  2001-08       Impact factor: 3.685

6.  Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation.

Authors:  R J Mark; Z Pang; J W Geddes; K Uchida; M P Mattson
Journal:  J Neurosci       Date:  1997-02-01       Impact factor: 6.167

Review 7.  Neuroimaging and genetic assessment for early diagnosis of Alzheimer's disease.

Authors:  G W Small
Journal:  J Clin Psychiatry       Date:  1996       Impact factor: 4.384

Review 8.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

9.  Endogenous antioxidant activities in relation to concurrent vitamins A, C, and E intake in dementia.

Authors:  Naji Tabet; David Mantle; Zuzana Walker; Martin Orrell
Journal:  Int Psychogeriatr       Date:  2002-03       Impact factor: 3.878

10.  Elevated levels of tau in cerebrospinal fluid: implications for the antemortem diagnosis of Alzheimer's disease elevated levels of tau in cerebrospinal fluid: implications for the antemortem diagnosis of Alzheimer's disease.

Authors:  J Q Trojanowski; C M Clark; H Arai; V M Lee
Journal:  J Alzheimers Dis       Date:  1999-11       Impact factor: 4.472

View more
  23 in total

Review 1.  Natural products as a source of Alzheimer's drug leads.

Authors:  Philip Williams; Analia Sorribas; Melanie-Jayne R Howes
Journal:  Nat Prod Rep       Date:  2010-11-12       Impact factor: 13.423

2.  Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer's disease.

Authors:  Eric M Blalock; Heather M Buechel; Jelena Popovic; James W Geddes; Philip W Landfield
Journal:  J Chem Neuroanat       Date:  2011-07-02       Impact factor: 3.052

Review 3.  Indices of metabolic dysfunction and oxidative stress.

Authors:  Gemma Casadesus; Paula I Moreira; Akihiko Nunomura; Sandra L Siedlak; William Bligh-Glover; Elizabeth Balraj; Grace Petot; Mark A Smith; George Perry
Journal:  Neurochem Res       Date:  2007-03-07       Impact factor: 3.996

4.  Effects of high fat diet on Morris maze performance, oxidative stress, and inflammation in rats: contributions of maternal diet.

Authors:  Christy L White; Paul J Pistell; Megan N Purpera; Sunita Gupta; Sun-Ok Fernandez-Kim; Taylor L Hise; Jeffrey N Keller; Donald K Ingram; Christopher D Morrison; Annadora J Bruce-Keller
Journal:  Neurobiol Dis       Date:  2009-04-15       Impact factor: 5.996

Review 5.  Intersection between metabolic dysfunction, high fat diet consumption, and brain aging.

Authors:  Romina M Uranga; Annadora J Bruce-Keller; Christopher D Morrison; Sun Ok Fernandez-Kim; Philip J Ebenezer; Le Zhang; Kalavathi Dasuri; Jeffrey N Keller
Journal:  J Neurochem       Date:  2010-05-06       Impact factor: 5.372

6.  Oxidative damage is present in the fatal brain edema of diabetic ketoacidosis.

Authors:  William H Hoffman; Sandra L Siedlak; Yang Wang; Rudy J Castellani; Mark A Smith
Journal:  Brain Res       Date:  2010-10-30       Impact factor: 3.252

7.  Saturated long-chain fatty acids activate inflammatory signaling in astrocytes.

Authors:  Sunita Gupta; Alecia G Knight; Shruti Gupta; Jeffrey N Keller; Annadora J Bruce-Keller
Journal:  J Neurochem       Date:  2012-02-06       Impact factor: 5.372

8.  Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease.

Authors:  Fei Liu; Jianhua Shi; Hitoshi Tanimukai; Jinhua Gu; Jianlan Gu; Inge Grundke-Iqbal; Khalid Iqbal; Cheng-Xin Gong
Journal:  Brain       Date:  2009-05-18       Impact factor: 13.501

9.  A role for heme in Alzheimer's disease: heme binds amyloid beta and has altered metabolism.

Authors:  Hani Atamna; William H Frey
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

10.  Down-regulation of aminolevulinate synthase, the rate-limiting enzyme for heme biosynthesis in Alzheimer's disease.

Authors:  Barney E Dwyer; Mark A Smith; Sandy L Richardson; George Perry; Xiongwei Zhu
Journal:  Neurosci Lett       Date:  2009-05-27       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.